H-1B sponsorship profile: Acerand Therapeutics USA Limited. Across U.S. Department of Labor LCA disclosures, Acerand Therapeutics USA Limited filed 1 Labor Condition Applications covering 1 H-1B worker positions between fiscal year 2024 and fiscal year 2024. The employer’s DOL certification rate sits at 100% (1 certified of 1 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Acerand Therapeutics USA Limited’s H-1B petitions range from $104,348 at the low end to $104,348 at the high end, with a petition-weighted average of $104,348. That range reflects the mix of occupations the company sponsors, led by Cellular and Molecular Biologist (1 petitions at $104,348 avg). H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Acerand Therapeutics USA Limited is headquartered in Carmel, IN under NAICS code 541714, and places H-1B workers across 1 state, most heavily in IN. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Acerand Therapeutics USA Limited ranks. By H-1B petition volume, Acerand Therapeutics USA Limited is #72,571 of 119,880 employers nationally and #695 of 1,210 employers headquartered in IN. Both ranks are computed live from the same underlying petition counts, not a separate estimate.